LevitasBio looks forward to meeting you at Johns Hopkin's 2nd Annual Single Cell Symposium on September 29-30, 2022 in the Turner Concourse. Attend our company showcase to learn how our novel cell enrichment technology elevates your single cell work by: Uncovering native scRNA-seq transcriptomic signatures Enriching the highest quality cells and robust scRNA data Enabling […]

LevitasBio looks forward to meeting you at Cincinnati Children's Hospital's 12th Annual Imaging and Cytometry Research Day! Stop by our table, or attend our talk to learn more about our novel cell enrichment technology and to find out if LeviCell is better than FACS... Location: S1.203/4 Time: 12:00 - 12:15 pm, lunch box provided Presentation: […]

On Wednesday, December 14, 2022 from 11am to 1pm, our team will be on hand at Bio-EV's Genomics Showcase Fair to introduce you to the world of levitation. Stop by to learn how we levitate cells, and the benefits this novel technology offers over traditional cell sorting and isolation methods you may be using today. Meet […]

Empower Your Immuno-oncology Research With Targeted Enrichment of Specific Immune Cell Markers LevitasBio is excited to attend this year’s Society for Immunotherapy of Cancer Annual Meeting, held November 8-12, 2022 in Boston, MA. Our team members, Melissa Ma and Camila Egidio, will be on-site, and ready to discuss your cellular analysis needs. Request a meeting to learn […]

LevitasBio is excited to participate in this year’s American Society for Cell Biology Annual Meeting, held December 3-7, 2022 in Washington, DC. Dr. Debia Wakhloo, Product Application Scientist, will discuss how our technology can minimize isolation-induced inflammatory response signaling in immune cells during her poster presentation. Presentation: Sunday, December 4, 2022 1:45 pm EST Exhibit […]

Extensive manipulation, mechanical force, and labelling methods used to enrich cells activate transcriptional programs that mask molecular profiles truly significant to any underlying disease. The consequence is identification of drug targets that are not relevant to the biological process under study. Based on Nakhoda and Olszanski, 2022 (Addressing Recent Failures in Immuno-Oncology Trials to Guide […]

Cell and Gene therapy provides great promise to treat many diseases, such as B-cell malignancies, with FDA-approved CAR-T cells. Immune cells are first isolated from the patient or donor, followed by activation, expansion, and ex vivo genetic modification of selected immune cells. It is important to control and monitor the quantity and quality of immune […]

Unlock Previously Inaccessible Samples LevitasBio can't wait to meet you at this year’s NextGen Omics US 2023, held March 30-31, 2023, in Boston, MA. Our fantastic team will be on-site and are excited to show you how the LeviCell system powers your omics research with true biological signatures and real cellular insights. Stop by booth […]

In recent years, single-cell RNA sequencing has transformed our understanding of cellular heterogeneity within highly complex tissues and organs, revealing thus far undiscovered cell types and states and characterizing perturbations in disease. However, despite the advances in single-cell technologies, not all tissues and samples can be successfully profiled. This is often due to poor sample […]

The ABRF Annual Meeting is an international program that provides timely updates on cutting-edge science and its execution in a shared resource/core facility setting. The meeting offers informative and practical workshops and ample networking opportunities with academics, corporate, and technology partner colleagues.   Join our Senior VP of Research & Development, Kevin Travers, Ph.D., at […]